Graham Capital Management L.P. Invests $1.29 Million in Option Care Health, Inc. (NASDAQ:OPCH)

Graham Capital Management L.P. acquired a new position in Option Care Health, Inc. (NASDAQ:OPCH) during the fourth quarter, Holdings Channel.com reports. The firm acquired 55,710 shares of the company’s stock, valued at approximately $1,292,000.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Murphy & Mullick Capital Management Corp acquired a new stake in shares of Option Care Health in the fourth quarter worth $26,000. UMB Bank n.a. increased its stake in shares of Option Care Health by 41.7% in the fourth quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock worth $27,000 after acquiring an additional 346 shares during the period. Signaturefd LLC increased its stake in shares of Option Care Health by 487.9% in the fourth quarter. Signaturefd LLC now owns 1,211 shares of the company’s stock worth $28,000 after acquiring an additional 1,005 shares during the period. Quadrant Capital Group LLC increased its stake in shares of Option Care Health by 172.8% in the fourth quarter. Quadrant Capital Group LLC now owns 1,735 shares of the company’s stock worth $40,000 after acquiring an additional 1,099 shares during the period. Finally, Johnson Financial Group Inc. acquired a new stake in shares of Option Care Health in the fourth quarter worth $47,000. Institutional investors and hedge funds own 98.05% of the company’s stock.

Option Care Health Stock Performance

OPCH opened at $31.86 on Tuesday. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. The company has a market cap of $5.22 billion, a price-to-earnings ratio of 26.77, a PEG ratio of 2.30 and a beta of 0.76. Option Care Health, Inc. has a 52-week low of $21.39 and a 52-week high of $35.53. The firm’s fifty day simple moving average is $33.19 and its two-hundred day simple moving average is $28.91.

Option Care Health (NASDAQ:OPCH) last posted its quarterly earnings data on Tuesday, April 29th. The company reported $0.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.04. The business had revenue of $1.33 billion for the quarter, compared to the consensus estimate of $1.26 billion. Option Care Health had a net margin of 4.37% and a return on equity of 15.30%. The company’s revenue was up 16.3% compared to the same quarter last year. During the same period last year, the firm posted $0.26 earnings per share. Equities analysts anticipate that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several analysts recently commented on the stock. JPMorgan Chase & Co. raised their price target on shares of Option Care Health from $40.00 to $41.00 and gave the company an “overweight” rating in a research report on Thursday, March 6th. UBS Group upgraded shares of Option Care Health from a “neutral” rating to a “buy” rating and raised their price target for the company from $38.00 to $40.00 in a research report on Wednesday, April 30th. Jefferies Financial Group upgraded shares of Option Care Health from a “hold” rating to a “buy” rating and raised their price target for the company from $26.00 to $35.00 in a research report on Thursday, January 23rd. JMP Securities restated a “market outperform” rating and set a $36.00 price target on shares of Option Care Health in a research report on Tuesday, April 22nd. Finally, Bank of America upgraded shares of Option Care Health from a “neutral” rating to a “buy” rating and raised their price target for the company from $26.00 to $33.00 in a research report on Monday, January 13th. One equities research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company. According to MarketBeat.com, Option Care Health has an average rating of “Moderate Buy” and a consensus target price of $35.50.

Insider Buying and Selling at Option Care Health

In other news, insider Michael Bavaro sold 30,996 shares of the firm’s stock in a transaction dated Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the transaction, the insider now directly owns 44,974 shares of the company’s stock, valued at approximately $1,495,835.24. This trade represents a 40.80% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Insiders own 0.64% of the company’s stock.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.